• Popular
    • Medicine
    • Radiology
    • Cardiology
    • Surgery
    • Nanomedicine
    • Military Medicine
    • Rehab
  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS
  • Submit PR
  • Log in
Medgadget
Medgadget
  • Popular
    • Medicine
      Biomimetic Construct Models Burn Injuries

      Biomimetic Construct Models Burn Injuries

      Moving Cells Using Ultrasound

      Moving Cells Using Ultrasound

      Smartphone Photos to Detect Anemia

      Smartphone Photos to Detect Anemia

      Ultrasound Catheter to Treat Hypertension

      Ultrasound Catheter to Treat Hypertension

    • Radiology
      Imaging Technique Reveals Contraction Patterns During Labor

      Imaging Technique Reveals Contraction Patterns During Labor

      Moving Cells Using Ultrasound

      Moving Cells Using Ultrasound

      Ultrasound Catheter to Treat Hypertension

      Ultrasound Catheter to Treat Hypertension

      Antibacterial Smart Sutures Visible in CT Scans

      Antibacterial Smart Sutures Visible in CT Scans

    • Cardiology
      Scientists Grow Electrodes Inside The Body

      Scientists Grow Electrodes Inside The Body

      Patient-Specific Soft Robotic Heart Replicas for Treatment Planning

      Patient-Specific Soft Robotic Heart Replicas for Treatment Planning

      Tiny Patch for Cardiac Ultrasound Imaging

      Tiny Patch for Cardiac Ultrasound Imaging

      Belt Monitors Heart Failure Patients

      Belt Monitors Heart Failure Patients

    • Surgery
      Biomimetic Construct Models Burn Injuries

      Biomimetic Construct Models Burn Injuries

      Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

      Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

      Self-Assembling Peptides as a Bioink

      Self-Assembling Peptides as a Bioink

      3D Bioengineered Skin Grafts Fit Complex Anatomy

      3D Bioengineered Skin Grafts Fit Complex Anatomy

    • Nanomedicine
      Bottlebrush Particle for Synergistic Drug Combinations

      Bottlebrush Particle for Synergistic Drug Combinations

      Extra Hot Nanoparticles for Cancer Therapy

      Extra Hot Nanoparticles for Cancer Therapy

      Making Tumors Tastier for the Immune System

      Making Tumors Tastier for the Immune System

      Improved Membrane Coating for Anti-Cancer Nanoparticles

      Improved Membrane Coating for Anti-Cancer Nanoparticles

    • Military Medicine
      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fabric Makes Electricity from Movement to Power Wearables

      Fabric Makes Electricity from Movement to Power Wearables

      Wearable Uses Microneedles to Track Metabolism

      Wearable Uses Microneedles to Track Metabolism

    • Rehab
      Empowering Stroke Survivors: Interview with Kirsten Carroll, General Manager at Kandu Health

      Empowering Stroke Survivors: Interview with Kirsten Carroll, General Manager at Kandu Health

      Smart Walking Stick for Visually Impaired People

      Smart Walking Stick for Visually Impaired People

      Implantable Device Adheres to Muscle, Treats Atrophy

      Implantable Device Adheres to Muscle, Treats Atrophy

      Non-Invasive Spinal Modulation for Cerebral Palsy

      Non-Invasive Spinal Modulation for Cerebral Palsy

  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Log in
  • Submit PR
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS

Impact of COVID-19 on Liquid Biopsy Market is growing at impressive CAGR of 28.9% by 2023

January 24th, 2019 Allied Market Research Releases

UPDATE AVAILABLE ON-DEMAND

“The minimally invasive nature of liquid biopsy tests and the array of different tumor information provided by these tests are expected to attract the patients with higher purchasing power and fuel the innovations and market growth. “

The global liquid biopsy market is estimated to reach $3.80 billion by 2023 registering a CAGR of 28.9% during the period 2017–2023. Liquid biopsy has benefitted the healthcare and therapeutic research sectors with its accuracy and molecular aspects. Most importantly, it is non-invasive, cost-effective, and less painful, which has proved to be a miracle treatment for cancer patients. It provides the cancer profile at an early stage and guides the doctors and physicians to follow an appropriate therapy, improving the survival rate of the cancer patients. Liquid biopsy can also be used for rare forms of cancer. Other than that, the surge in the global prevalence of cancer is another contributing factor providing growth to the global liquid biopsy market. However, with scientific advancements, researchers are learning more regarding the potential of liquid biopsy to detect mutations. Thus, the future is expected to be revolutionary for sure.

The number of patients suffering from cancer have escalated drastically within last few years. While observing a tumor or lump in a patient, the first step doctors take is to perform tissue biopsy in pinpoint any indications of cancer. Tissue biopsy is a process to collect body cells for microscopic analysis for better understanding of the disease. The microscopic analysis of the cells can determine whether the disease is cancer or not. Moreover, it can illustrate its type and provide further information regarding the patient’s prognosis. Furthermore, it can help to modify the treatment strategy. However, tissue biopsy involves a large needle, an endoscope, and sometimes an open surgery, which could be painful, costly, and a bit risky.

Click Here To Access Free Sample Report @ https://www.alliedmarketresearch.com/request-sample/1891

Global Liquid Biopsy Market Report provides an overview of the market based on key parameters such as market size, sales, sales analysis and key drivers. The market size of the market is expected to grow on a large scale during the forecast period (2019-2026). This report covers the impact of the latest COVID-19 on the market. The coronavirus epidemic (COVID-19) has affected all aspects of life around the world. This has changed some of the market situation. The main purpose of the research report is to provide users with a broad view of the market. Initial and future assessments of rapidly changing market scenarios and their impact are covered in the report.

Tissue biopsy has been a difficult process as it was uncomfortable for patients and may include innate clinical risks, potential surgical complications, and economic concerns. Furthermore, some tumors are not easily accessible for tissue biopsy as the patients may have various health conditions. Apart from this, tissue biopsy cannot be recommended to those patients who are going through antiangiogenic treatment. Such issues make it difficult to perform frequent biopsies in intervals on a patient. Since tumors get developed over time, performing this procedure could bring more discomfort. Nevertheless, this process helps to detect and find information regarding the type of and development cancer.

Liquid biopsy to be less painful, cost-efficient, and convenient for cancer patients:

Liquid biopsy revolutionized the way of diagnosing and treating cancer. It is an alternative for tissue biopsy that can analyze tumors with the help of bodily fluids, including blood, urine, and saliva. Liquid biopsy is a non-invasive method of diagnosing and monitoring cancer-related information with the help of biological markers. Previously various liquid biopsy tests included analysis of several kinds of tumor materials including DNA, RNA, proteins, and exosomes.

A liquid biopsy can provide genetic information of all cancer-related lesions and offer opportunities to methodically track enlarging genomes. The tests can detect molecules that favor cancer in patients with the help of samples of bodily fluids such as blood, saliva cerebrospinal fluid, and urine. Moreover, biopsies provide the histological definition of the disease in cancer patients and expose details regarding the genetic outline of the tumor to predict the evolution of the disease in the patient’s body and response to therapies.

Liquid biopsy provides information regarding the further development of cancer in a patient’s body and offers opportunities to improve the survival rate of the cancer patient. It can be used to predict the chances of the disease returning after completing the treatment.

Detecting circulating tumor DNA-based biopsies to detect cancer at an early stage:  

Liquid biopsy has been tested to analyze tumor DNA in the blood– ctDNA. The ctDNA-based liquid biopsies are vital to detect cancer at an early stage, as it offers an additional time for the essential treatment to be successful. In some cases, liquid biopsies detected ctDNA in blood samples of patients earlier compared to other conventional method of diagnosis.

Check available discounts on this report @ https://www.alliedmarketresearch.com/purchase-enquiry/1891

Liquid biopsy is useful for frequent tests as it can guide the doctors regarding the development of the tumors. As some tumors are slow-growing and less or not at all harming, operating it might prove to be harmful and risky. Moreover, liquid biopsies provide an advanced understanding regarding evolving metastatic sites, recognizing tumors, and detecting the rate of cancer development in a patient.

One of the major advantages of ctDNA-based liquid biopsy is that they are useful for examining the patient’s responses to the therapy, during and after the treatment. Since it is non-invasive and easily repetitive, it can help clinicians to track the responses to understand what adjustments should be made in the course of treatment.

What’s more, a liquid biopsy provides inclusive imagery of all the cancerous indication in a patient’s body. Unlike tissue biopsy, liquid biopsy informs about the entire body and not just about the cancer-infected area. Liquid biopsy has proved effective for the patients suffering from metastatic gastrointestinal (GI) cancers, as it has presented rare alterations, guiding the doctors to treat accordingly. Liquid biopsy has changed the way of treating cancer over other conventional procedures. Furthermore, it can be used for treating rare type of cancers. Moreover, with further developments and improved therapies, liquid biopsy will garner more attention and would be widely accepted to treat cancer patients.

The key players analyzed in the report include

  • Biocept, Inc
  • Qiagen
  • Hoffmann-La Roche AG
  • Bio-Rad Laboratories Inc
  • Myriad Genetics
  • Others

Scope of the Report

Report Attribute Details
Market size available for years 2017-2023
Base year considered 2018
Forecast period 2018-2024
Forecast units Value (USD)
Segments covered Type, Product & Service
Geographies covered North America, Europe, Asia-Pacific, LAMEA

 Read More @ https://blog.alliedmarketresearch.com/liquid-biopsy-for-betecting-early-cancerous-symptoms-and-treating-patients-490

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

Sign up and submit a press release

Sponsored
machineMD and Varjo revolutionize the diagnosis of brain disorders with a VR-based eye-tracking solution 

machineMD and Varjo revolutionize the diagnosis of brain disorders with a VR-based eye-tracking solution 

Ax-Surgi Hemostat gets FDA Clearance for Surgical Bleeding Control

Ax-Surgi Hemostat gets FDA Clearance for Surgical Bleeding Control

Clarius Report Finds 85% of Clinicians Believe Ultrasound Leads to Better Patient Outcomes

Clarius Report Finds 85% of Clinicians Believe Ultrasound Leads to Better Patient Outcomes

New AASLD Practice Guidance Calls for the Use of Noninvasive Liver Evaluations for Earlier Detection of NAFLD and NASH

New AASLD Practice Guidance Calls for the Use of Noninvasive Liver Evaluations for Earlier Detection of NAFLD and NASH

C-mo Medical Solutions extends seed investment round to €4.8 million to transform cough monitoring

C-mo Medical Solutions extends seed investment round to €4.8 million to transform cough monitoring

interviews & reviews
Empowering Stroke Survivors: Interview with Kirsten Carroll, General Manager at Kandu Health

Empowering Stroke Survivors: Interview with Kirsten Carroll, General Manager at Kandu Health

Alpha TAU Killing Tumors With Highly Targeted Alpha Radiation

Alpha TAU Killing Tumors With Highly Targeted Alpha Radiation

Neuroimmune Modulation for Inflammatory Disease: Interview with Dr. Simhambhatla, President and CEO of SetPoint Medical

Neuroimmune Modulation for Inflammatory Disease: Interview with Dr. Simhambhatla, President and CEO of SetPoint Medical

Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

Exciting Medtech at the Healthcareᐩ Expo Taiwan

Exciting Medtech at the Healthcareᐩ Expo Taiwan

Medgadget Visits Healthcareᐩ Expo Taiwan

Medgadget Visits Healthcareᐩ Expo Taiwan

  • Subscribe
  • Contact us
  • Submit
  • About
  • Back to top
Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

  • About
  • Editorial policies
  • Contact
  • Terms of Service
  • Privacy
  • Submit press release
  • Advertise
© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.
Please support this website by adding us to your whitelist in your ad blocker. Ads are what helps us bring you premium content! Thank you!
Posting....
  • Facebook
  • Twitter
  • LinkedIn
  • Reddit
  • Email